Recent work suggested that the reduction in both food intake and body weight observed in response to combined treatment with GLP-1RAs and PYY 3-36 results in synergistically-enhanced activation of discrete hypothalamic and brainstem circuits that regulate appetite, including the arcuate nucleus (ARC), the paraventricular nuclei of the hypothalamus (PVNs), the central nucleus of the amygdala (CeA), and the hindbrain (AP/NTS) 10,12,21,44
Read More Who is a good candidate for GLP-1 weight loss injections
Iron and the pathophysiology of diabetes
By reducing NNMT activity, the bodys ability to break down fat and generate cellular energy is restored
The diagnosis of EDKA can be challenging due to its atypical presentation, and it is important to consider this diagnosis in patients with unexplained metabolic acidosis, especially those on SGLT2 inhibitors